1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUPHORIA THERAPEUTICS INC.
Neuphoria Therapeutics Inc. XNAS: NEUP

Neuphoria Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral...

Read More
13.00 1.05 (8.79%)
New 52W High in past week
48,650
XNAS Volume

XNAS 03 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Neuphoria Therapeutics Inc. is on 05 Sep 2025 for the purpose of H.C. Wainwright 27(th) Annual Global Investment Conference See details
Durability score
Not Eligible
-
Valuation Score
Mid Valuation
41.5 / 100
Momentum Score
Technically Bullish
79.2 / 100
Analyst Price Target
No estimates available

24

S

2

W

1

O

2

T

SWOT Analysis

Neuphoria Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..